المؤلفون: Zhang N; Department of Oncology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China., Chang J; Department of Oncology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China., Liu P; Department of Oncology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China., Tian X; Department of Oncology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China., Yu J; Department of Oncology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jun 10; Vol. 15, pp. 1400262. Date of Electronic Publication: 2024 Jun 10 (Print Publication: 2024).

نوع المنشور: Systematic Review; Meta-Analysis; Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/blood , Carcinoma, Non-Small-Cell Lung*/mortality , Carcinoma, Non-Small-Cell Lung*/immunology , Immune Checkpoint Inhibitors*/therapeutic use , Lung Neoplasms*/drug therapy , Lung Neoplasms*/blood , Lung Neoplasms*/mortality , Lung Neoplasms*/immunology , B7-H1 Antigen*/blood , Biomarkers, Tumor*/blood, Humans ; Prognosis

المؤلفون: Hu M; Department of Oncology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China., Zhong C; Department of Oncology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China., Wang J; Department of Oncology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China., Chen J; Department of Oncology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.; Jiangxi Medical College, Nanchang University, Nanchang, China., Zhou T; Department of Chinese and Western Medicine Oncology, Jiangxi Provincial People's Hospital, Nanchang, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 May 07; Vol. 15, pp. 1399975. Date of Electronic Publication: 2024 May 07 (Print Publication: 2024).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/therapy , ErbB Receptors*/genetics , ErbB Receptors*/antagonists & inhibitors , Exons*/genetics, Humans ; Protein Kinase Inhibitors/therapeutic use ; Immunotherapy/methods ; Mutagenesis, Insertional ; Molecular Targeted Therapy ; Mutation ; Animals

المؤلفون: Pandya P; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, United States.; Graduate School of Biomedical Sciences, Mayo Clinic, Jacksonville, FL, United States., Al-Qasrawi DS; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, United States., Klinge S; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, United States.; Department of Biology, University of North Florida, Jacksonville, FL, United States., Justilien V; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, United States.; Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL, United States.

المصدر: Frontiers in immunology [Front Immunol] 2024 May 03; Vol. 15, pp. 1369356. Date of Electronic Publication: 2024 May 03 (Print Publication: 2024).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/metabolism , Extracellular Vesicles*/metabolism , Neoplastic Stem Cells*/metabolism , Neoplastic Stem Cells*/pathology , Lung Neoplasms*/pathology , Lung Neoplasms*/metabolism , Tumor Microenvironment*, Humans ; Animals ; Biomarkers, Tumor/metabolism ; Cell Communication

المؤلفون: Patwardhan KA; Oncology Data Science, AstraZeneca, Waltham, MA, United States., RaviPrakash H; Oncology Data Science, AstraZeneca, Waltham, MA, United States., Nikolaou N; Oncology Data Science, AstraZeneca, Cambridge, United Kingdom., Gonzalez-García I; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, AstraZeneca, Cambridge, United Kingdom., Salazar JD; Oncology Data Science, AstraZeneca, Cambridge, United Kingdom., Metcalfe P; Oncology Data Science, AstraZeneca, Cambridge, United Kingdom., Reischl J; Diagnostic Science, Precision Medicine, AstraZeneca, Gothenburg, Sweden.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jun 10; Vol. 15, pp. 1383644. Date of Electronic Publication: 2024 Jun 10 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/mortality , Lung Neoplasms*/diagnostic imaging , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Carcinoma, Non-Small-Cell Lung*/mortality , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/diagnostic imaging , Carcinoma, Non-Small-Cell Lung*/pathology , Tomography, X-Ray Computed*/methods , Antibodies, Monoclonal*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Aged ; Machine Learning ; Risk Assessment ; Antineoplastic Agents, Immunological/therapeutic use ; Prognosis ; B7-H1 Antigen ; Radiomics

المؤلفون: Kuang Z; College of Public Health, The Ohio State University, Columbus, OH, United States., Miao J; College of Arts and Sciences, The Ohio State University, Columbus, OH, United States., Zhang X; Department of Biomedical Informatics, The Ohio State University, Columbus, OH, United States.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jun 07; Vol. 15, pp. 1327449. Date of Electronic Publication: 2024 Jun 07 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Small Cell Lung Carcinoma*/drug therapy , Small Cell Lung Carcinoma*/blood , Small Cell Lung Carcinoma*/immunology , Small Cell Lung Carcinoma*/mortality , Neutrophils*/immunology , Immune Checkpoint Inhibitors*/therapeutic use , Lung Neoplasms*/drug therapy , Lung Neoplasms*/blood , Lung Neoplasms*/mortality , Lung Neoplasms*/immunology , Lymphocytes*/immunology , Biomarkers, Tumor*/blood, Humans ; Male ; Female ; Aged ; Middle Aged ; Prognosis ; Serum Albumin, Human/analysis ; Serum Albumin/analysis ; Aged, 80 and over ; Retrospective Studies ; Adult ; Lymphocyte Count

المؤلفون: Ding C; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China., Huang H; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China., Wu D; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China., Chen C; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China., Hua Y; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China., Liu J; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China., Li Y; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China., Liu H; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China., Chen J; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 May 24; Vol. 15, pp. 1369073. Date of Electronic Publication: 2024 May 24 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor* , Carcinoma, Non-Small-Cell Lung*/immunology , Carcinoma, Non-Small-Cell Lung*/therapy , Lung Neoplasms*/immunology , Lung Neoplasms*/therapy , Lung Neoplasms*/genetics , Immunotherapy*/methods, Humans ; Animals ; Mice ; Cadherins/metabolism ; Cadherins/genetics ; Cell Line, Tumor ; Prognosis ; Gene Expression Regulation, Neoplastic ; Cell Proliferation ; Cell Movement ; Computational Biology/methods

المؤلفون: Liu X; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.; Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China., Zhang Z; Department of Radiation Oncology, Shandong University Cancer Center, Jinan, Shandong, China., Yuan J; Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China., Yu J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.; Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.; Department of Radiation Oncology, Shandong University Cancer Center, Jinan, Shandong, China., Chen D; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.; Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 May 10; Vol. 15, pp. 1396719. Date of Electronic Publication: 2024 May 10 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Microenvironment*/immunology , Carcinoma, Non-Small-Cell Lung*/immunology , Carcinoma, Non-Small-Cell Lung*/mortality , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/immunology , Lung Neoplasms*/mortality , Lung Neoplasms*/pathology , Lung Neoplasms*/metabolism , Antigens, CD*/metabolism , Protein Tyrosine Phosphatase, Non-Receptor Type 11*/metabolism , Antigens, Differentiation, Myelomonocytic*/metabolism , Tumor-Associated Macrophages*/immunology , Tumor-Associated Macrophages*/metabolism, Humans ; Female ; Male ; Middle Aged ; Aged ; Biomarkers, Tumor/metabolism ; Macrophages/immunology ; Macrophages/metabolism ; Prognosis ; Adult ; CD68 Molecule

المؤلفون: Taniguchi H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Chavan SS; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Chow A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Chan JM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Department of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Mukae H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Weill Cornell Medical College, New York, NY, United States., Sen T; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

المصدر: Frontiers in immunology [Front Immunol] 2024 Mar 12; Vol. 15, pp. 1348982. Date of Electronic Publication: 2024 Mar 12 (Print Publication: 2024).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Small Cell Lung Carcinoma*/drug therapy , Carcinoma, Non-Small-Cell Lung*/drug therapy , Lung Neoplasms*/pathology, Humans ; B7-H1 Antigen ; Cisplatin/therapeutic use ; Etoposide/therapeutic use ; Biomarkers ; Tumor Microenvironment

المؤلفون: Liang X; Phase 1 Clinical Trial Laboratory, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China., Xiao H; Department of Scientific Research, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China., Li H; Phase 1 Clinical Trial Laboratory, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China., Chen X; Phase 1 Clinical Trial Laboratory, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.; Department of Clinical Pharmacy, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China., Li Y; Department of Clinical Pharmacy, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Apr 30; Vol. 15, pp. 1396752. Date of Electronic Publication: 2024 Apr 30 (Print Publication: 2024).

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/immunology , Lung Neoplasms*/drug therapy , Immune Checkpoint Inhibitors*/adverse effects , Immune Checkpoint Inhibitors*/therapeutic use , Pharmacovigilance* , United States Food and Drug Administration*, Humans ; United States ; Randomized Controlled Trials as Topic ; Drug-Related Side Effects and Adverse Reactions/etiology ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Adverse Drug Reaction Reporting Systems ; Bayes Theorem ; Retrospective Studies

المؤلفون: Zheng J; Department of Radiation Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China., Deng Y; Department of Medical Oncology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China., Huang B; Department of Obstetrics and Gynecology, Quanzhou Medical College People's Hospital Affiliated, Quanzhou, Fujian, China., Chen X; Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.; The Graduate School of Fujian Medical University, Fuzhou, Fujian, China.; Interdisciplinary Institute of Medical Engineering of Fuzhou University, Fuzhou, Fujian, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Apr 26; Vol. 15, pp. 1387896. Date of Electronic Publication: 2024 Apr 26 (Print Publication: 2024).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/mortality , Carcinoma, Non-Small-Cell Lung*/immunology , Carcinoma, Non-Small-Cell Lung*/pathology , AMP-Activated Protein Kinase Kinases* , Lung Neoplasms*/genetics , Lung Neoplasms*/mortality , Lung Neoplasms*/immunology , Lung Neoplasms*/pathology , Mutation* , Protein Serine-Threonine Kinases*/genetics, Humans ; Female ; Male ; Prognosis ; Middle Aged ; Aged ; Biomarkers, Tumor/genetics ; Lymphocytes, Tumor-Infiltrating/immunology ; Adult ; Kaplan-Meier Estimate